← FDA Drug Approvals (Drugs@FDA)
NIFEDIPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2022-03-29
Drug application
- FDA Application #
ANDA216067- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NIFEDIPINE
- Generic name
- NIFEDIPINE
- Active ingredients
- NIFEDIPINE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALKEM LABS LTD
- Manufacturer
- Ascend Laboratories, LLC
- First approval
- 2022-03-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown